Testing effectiveness (Phase 2)Ended earlyNCT01813019
What this trial is testing
Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
Who this might be right for
Patient Diagnosed With OCD and Resistant to SSRI TreatmentFailed SSRI Over 12 Weeks at Appropriate Doses
Novartis Pharmaceuticals 50